NAD+ auxotrophy is bacteriocidal for the tubercle bacilli

Molecular Microbiology

Volumn 76, Issue 2, 2010, Pages 365-377

  Vilchèze, Catherine ^a   Weinrick, Brian ^a   Wong, Ka Wing ^a   Chen, Bing ^a   Jacobs Jr , William ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; PROTEIN PNCA; UNCLASSIFIED DRUG; NICOTINAMIDE;

ANIMAL CELL; ARTICLE; AUXOTROPHY; BACTERIAL GROWTH; BACTERIAL STRAIN; BIOSYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; GROWTH RATE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANIMAL; BACTERIAL COUNT; BIOLOGICAL MODEL; DEFICIENCY; DISEASE MODEL; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; TUBERCULOSIS; VIRULENCE;

ANIMALS; BIOSYNTHETIC PATHWAYS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; MICE; MICROBIAL VIABILITY; MODELS, BIOLOGICAL; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NAD; NIACINAMIDE; TUBERCULOSIS; VIRULENCE;

BACILLI (CLASS); BACILLUS (BACTERIUM); BOVINAE; MUS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 77951165552     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2010.07099.x     Document Type: Article

References (43)

1. Bardarov, S., Bardarov, S., Jr., Pavelka, M.S., Jr., Sambandamurthy, V., Larsen, M., Tufariello, J., et al 2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology 148 : 3007 3017.
2. Begley, T.P., Kinsland, C., Mehl, R.A., Osterman, A. Dorrestein, P. (2001) The biosynthesis of nicotinamide adenine dinucleotides in bacteria. Vitam Horm 61 : 103 119.
3. Bekierkunst, A. Artman, M. (1962) Tissue metabolism in infection. DPNase activity, DPN levels, and DPN-linked dehydrogenases in tissues from normal and tuberculous mice. Am Rev Respir Dis 86 : 832 838.
4. Betts, J.C., Lukey, P.T., Robb, L.C., McAdam, R.A. Duncan, K. (2002) Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 43 : 717 731.
5. Boshoff, H.I., Myers, T.G., Copp, B.R., McNeil, M.R., Wilson, M.A. Barry, C.E., 3rd. (2004) The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism: novel insights into drug mechanisms of action. J Biol Chem 279 : 40174 40184.
6. Boshoff, H.I., Xu, X., Tahlan, K., Dowd, C.S., Pethe, K., Camacho, L.R., et al 2008) Biosynthesis and recycling of nicotinamide cofactors in Mycobacterium tuberculosis. An essential role for NAD in nonreplicating bacilli. J Biol Chem 283 : 19329 19341.
7. Cheng, S.J., Thibert, L., Sanchez, T., Heifets, L. Zhang, Y. (2000) pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother 44 : 528 532.
8. Eker, B., Ortmann, J., Migliori, G.B., Sotgiu, G., Muetterlein, R., Centis, R., et al 2008) Multidrug- and extensively drug-resistant tuberculosis, Germany. Emerg Infect Dis 14 : 1700 1706.
9. Foster, J.W. Moat, A.G. (1980) Nicotinamide adenine dinucleotide biosynthesis and pyridine nucleotide cycle metabolism in microbial systems. Microbiol Rev 44 : 83 105.
10. Gerdes, S.Y., Scholle, M.D., D'Souza, M., Bernal, A., Baev, M.V., Farrell, M., et al 2002) From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J Bacteriol 184 : 4555 4572.
11. Gholson, R.K. (1966) The pyridine nucleotide cycle. Nature 212 : 933 935.
12. Gordhan, B.G., Smith, D.A., Alderton, H., McAdam, R.A., Bancroft, G.J. Mizrahi, V. (2002) Construction and phenotypic characterization of an auxotrophic mutant of Mycobacterium tuberculosis defective in L-arginine biosynthesis. Infect Immun 70 : 3080 3084.
13. Grange, J.M. (2001) Mycobacterium bovis infection in human beings. Tuberculosis (Edinb) 81 : 71 77.
14. Hondalus, M.K., Bardarov, S., Russell, R., Chan, J., Jacobs, W.R., Jr. Bloom, B.R. (2000) Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 68 : 2888 2898.
15. Jackson, M., Phalen, S.W., Lagranderie, M., Ensergueix, D., Chavarot, P., Marchal, G., et al 1999) Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun 67 : 2867 2873.
16. Kasarov, L.B. Moat, A.G. (1972) Metabolism of nicotinamide adenine dinucleotide in human and bovine strains of Mycobacterium tuberculosis. J Bacteriol 110 : 600 603.
17. Khan, J.A., Forouhar, F., Tao, X. Tong, L. (2007) Nicotinamide adenine dinucleotide metabolism as an attractive target for drug discovery. Expert Opin Ther Targets 11 : 695 705.
18. Kohanski, M.A., Dwyer, D.J., Hayete, B., Lawrence, C.A. Collins, J.J. (2007) A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130 : 797 810.
19. Konno, K. (1956) New chemical method to differentiate human-type tubercle bacilli from other mycobacteria. Science 124 : 985.
20. Konno, K., Kurzmann, R. Bird, K.T. (1957) The metabolism of nicotinic acid in Mycobacteria: a method for differentiating tubercle bacilli of human origin from other Mycobacteria. Am Rev Tuberc 75 : 529 537.
21. Konno, K., Kurzmann, R., Bird, K.T. Sbarra, A. (1958) Differentiation of human tubercle bacilli from atypical acid-fast bacilli. II. Clinical application. Am Rev Tuberc 77 : 675 680.
22. Konno, K., Nagayama, H. Oka, S. (1960) Differentiation of bovine tubercle bacilli from other mycobacteria by the determination of nicotinamidase activity. Am Rev Respir Dis 81 : 550 554.
23. Leonardo, M.R., Dailly, Y. Clark, D.P. (1996) Role of NAD in regulating the adhE gene of Escherichia coli. J Bacteriol 178 : 6013 6018.
24. Louw, G.E., Warren, R.M., Donald, P.R., Murray, M.B., Bosman, M., Van Helden, P.D., et al 2006) Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis 10 : 802 807.
25. Magni, G., Di Stefano, M., Orsomando, G., Raffaelli, N. Ruggieri, S. (2009) NAD(P) biosynthesis enzymes as potential targets for selective drug design. Curr Med Chem 16 : 1372 1390.
26. Pavelka, M.S., Jr. Jacobs, W.R., Jr. (1999) Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J Bacteriol 181 : 4780 4789.
27. Pope, H. Smith, D.T. (1946) Synthesis of B-complex vitamins by tubercle bacilli when grown in synthetic media. Am Rev Tuberc 54 : 559 563.
28. Prunier, A.L., Schuch, R., Fernandez, R.E., Mumy, K.L., Kohler, H., McCormick, B.A. Maurelli, A.T. (2007) nadA and nadB of Shigella flexneri 5a are antivirulence loci responsible for the synthesis of quinolinate, a small molecule inhibitor of Shigella pathogenicity. Microbiology 153 : 2363 2372.
29. Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., et al 2006) Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281 : 21745 21754.
30. Raynaud, C., Laneelle, M.A., Senaratne, R.H., Draper, P., Laneelle, G. Daffe, M. (1999) Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Microbiology 145 : 1359 1367.
31. San, K.Y., Bennett, G.N., Berrios-Rivera, S.J., Vadali, R.V., Yang, Y.T., Horton, E., et al 2002) Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli. Metab Eng 4 : 182 192.
32. + and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther 324 : 883 893.
33. Scorpio, A. Zhang, Y. (1996) Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus. Nat Med 2 : 662 667.
34. Sestini, S., Jacomelli, G., Pescaglini, M., Micheli, V. Pompucci, G. (2000) Enzyme activities leading to NAD synthesis in human lymphocytes. Arch Biochem Biophys 379 : 277 282. (Pubitemid 30637464)
35. Singh, P., Mishra, A.K., Malonia, S.K., Chauhan, D.S., Sharma, V.D., Venkatesan, K. Katoch, V.M. (2006) The paradox of pyrazinamide: an update on the molecular mechanisms of pyrazinamide resistance in Mycobacteria. J Commun Dis 38 : 288 298.
36. Smith, D.A., Parish, T., Stoker, N.G. Bancroft, G.J. (2001) Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun 69 : 1142 1150. (Pubitemid 32109583)
37. Sorci, L., Pan, Y., Eyobo, Y., Rodionova, I., Huang, N., Kurnasov, O., et al 2009) Targeting NAD biosynthesis in bacterial pathogens: structure-based development of inhibitors of nicotinate mononucleotide adenylyltransferase NadD. Chem Biol 16 : 849 861.
38. Stover, C.K., de la Cruz, V.F., Fuerst, T.R., Burlein, J.E., Benson, L.A., Bennett, L.T., et al 1991) New use of BCG for recombinant vaccines. Nature 351 : 456 460.
39. Velu, S.E., Cristofoli, W.A., Garcia, G.J., Brouillette, C.G., Pierson, M.C., Luan, C.H., et al 2003) Tethered dimers as NAD synthetase inhibitors with antibacterial activity. J Med Chem 46 : 3371 3381.
40. Velu, S.E., Mou, L., Luan, C.H., Yang, Z.W., DeLucas, L.J., Brouillette, C.G. Brouillette, W.J. (2007) Antibacterial nicotinamide adenine dinucleotide synthetase inhibitors: amide- and ether-linked tethered dimers with alpha-amino acid end groups. J Med Chem 50 : 2612 2621. (Pubitemid 46896069)
41. Windman, I. Bekierkunst, A. (1967) Oxidized and reduced forms of nicotinamide nucleotides in livers of tuberculous mice. Am Rev Respir Dis 96 : 296 298.
42. Yang, T. Sauve, A.A. (2006) NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. AAPS J 8 : E632 E643.
43. Zhang, H., Deng, J.Y., Bi, L.J., Zhou, Y.F., Zhang, Z.P., Zhang, C.G., et al 2008) Characterization of Mycobacterium tuberculosis nicotinamidase/ pyrazinamidase. FEBS J 275 : 753 762.